In summary, FOXR2 overexpression, linked to genetic variations and abnormal activation, plays a significant role in the development of pediatric high-grade gliomas and diffuse midline gliomas, contributing to the poor prognosis of these brain tumors. This evidence concerns the gene FOXR2 and central nervous system cancer.